01-10-2010 | Research Articles
Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain
Published in: Clinical and Translational Oncology | Issue 10/2010
Login to get access